Open AccessOutcomes of a drug shortage requiring switching in patients with ulcerative colitis
Author(s) -
Daniel R. van Langenberg,
Richard Kai-Yuan Cheng,
Mayur Garg
Publication year - 2020
Publication title -
world journal of gastrointestinal pathophysiology
Language(s) - English
Resource type - Journals
ISSN - 2150-5330
DOI - 10.4291/wjgp.v11.i2.32
Subject(s) - medicine , adverse effect , ulcerative colitis , economic shortage , cohort , incidence (geometry) , surgery , linguistics , philosophy , physics , disease , government (linguistics) , optics
Drug shortages are common yet their impact on patient care and their commercial ramifications has not been adequately researched. In Australia a shortage of balsalazide (2012-2013) necessitated substitution with alternative 5-aminosalicylate (5-ASA) formulations for ulcerative colitis (UC).